Keywords
Last Name
Institution

MICHELE K YORK

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
DivisionNeurology
Address7200 Cambridge Street, M.S. BCM609
9th Floor, Suite 9A
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Psychiatry & Behavioral Sciences
    DivisionPsychiatry & Behavioral Sciences


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. York MK, Moro E. No differences in neuropsychological outcomes between constant current and voltage current subthalamic deep brain stimulation for Parkinson's disease. Ann Transl Med. 2017 Apr; 5(7):177. PMID: 28480213.
      View in: PubMed
    2. Krishnan S, York MK, Backus D, Heyn PC. Coping With Caregiver Burnout When Caring for a Person With Neurodegenerative Disease: A Guide for Caregivers. Arch Phys Med Rehabil. 2017 Feb 06. PMID: 28185639.
      View in: PubMed
    3. Heyn PC, Hirsch MA, York MK, Backus D. Physical Activity Recommendations for the Aging Brain: A Clinician-Patient Guide. Arch Phys Med Rehabil. 2016 Jun; 97(6):1045-7. PMID: 27233994.
      View in: PubMed
    4. Bryant MS, Workman CD, Hou JG, Henson HK, York MK. Acute and Long-Term Effects of Multidirectional Treadmill Training on Gait and Balance in Parkinson Disease. PM R. 2016 May 10. PMID: 27178378.
      View in: PubMed
    5. Jacks A, Wainwright DA, Salazar L, Grimes R, York M, Strutt AM, Shahani L, Woods SP, Hasbun R. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015 Aug 24; 29(13):1711-4. PMID: 26372282.
      View in: PubMed
    6. Calleo JS, Amspoker AB, Sarwar AI, Kunik ME, Jankovic J, Marsh L, York M, Stanley MA. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7. PMID: 26047635.
      View in: PubMed
    7. Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9. PMID: 25185211.
      View in: PubMed
    8. Hack N, Akbar U, Thompson-Avila A, Fayad SM, Hastings EM, Moro E, Nestor K, Ward H, York M, Okun MS. Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. J Parkinsons Dis. 2014; 4(4):591-8. PMID: 25035311.
      View in: PubMed
    9. Wiszniewski W, Hunter JV, Hanchard NA, Willer JR, Shaw C, Tian Q, Illner A, Wang X, Cheung SW, Patel A, Campbell IM, Gelowani V, Hixson P, Ester AR, Azamian MS, Potocki L, Zapata G, Hernandez PP, Ramocki MB, Santos-Cortez RL, Wang G, York MK, Justice MJ, Chu ZD, Bader PI, Omo-Griffith L, Madduri NS, Scharer G, Crawford HP, Yanatatsaneejit P, Eifert A, Kerr J, Bacino CA, Franklin AI, Goin-Kochel RP, Simpson G, Immken L, Haque ME, Stosic M, Williams MD, Morgan TM, Pruthi S, Omary R, Boyadjiev SA, Win KK, Thida A, Hurles M, Hibberd ML, Khor CC, Van Vinh Chau N, Gallagher TE, Mutirangura A, Stankiewicz P, Beaudet AL, Maletic-Savatic M, Rosenfeld JA, Shaffer LG, Davis EE, Belmont JW, Dunstan S, Simmons CP, Bonnen PE, Leal SM, Katsanis N, Lupski JR, Lalani SR. TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. Am J Hum Genet. 2013 Aug 8; 93(2):197-210. PMID: 23810381; PMCID: PMC3738832.
    10. Hasbun R, Eraso J, Ramireddy S, Wainwright DA, Salazar L, Grimes R, York M, Strutt A. Screening for Neurocognitive Impairment in HIV Individuals: The Utility of the Montreal Cognitive Assessment Test. J AIDS Clin Res. 2012 Dec; 3(10):186. PMID: 23956944.
      View in: PubMed
    11. Strutt AM, Palcic J, Wager JG, Titus C, Macadam C, Brown J, Scott BM, Harati Y, Schulz PE, York MK. Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis. ISRN Neurol. 2012; 2012:912123. PMID: 22852095; PMCID: PMC3407622.
    12. Strutt AM, Ayanegui IG, Scott BM, Mahoney ML, York MK, San Miguel Montes LE. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012 Aug; 27(5):545-56. PMID: 22693138.
      View in: PubMed
    13. Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31. PMID: 22632922.
      View in: PubMed
    14. Hou JG, Wu LJ, Moore S, Ward C, York M, Atassi F, Fincher L, Nelson N, Sarwar A, Lai EC. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012 May; 18(4):377-81. PMID: 22236581.
      View in: PubMed
    15. Armento ME, Stanley MA, Marsh L, Kunik ME, York MK, Bush AL, Calleo JS. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51. PMID: 23939438.
      View in: PubMed
    16. Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinsons Dis. 2012; 2012:512892. PMID: 22135762; PMCID: PMC3216311.
    17. Strutt AM, Scott BM, Shrestha S, York MK. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011 Oct; 25(7):1253-65. PMID: 21951176.
      View in: PubMed
    18. Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8. PMID: 21689962.
      View in: PubMed
    19. Strutt AM, Simpson R, Jankovic J, York MK. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7. PMID: 21668586.
      View in: PubMed
    20. Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7. PMID: 21316292; PMCID: PMC3109216.
    21. Jawaid A, Poon M, Strutt AM, Rice LK, McDowell EJ, Salamone AR, Qureshi SU, Simpson E, Appel SH, York MK, Schulz PE. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24. PMID: 20880000.
      View in: PubMed
    22. Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8. PMID: 20500116.
      View in: PubMed
    23. Hannon PM, Kuo SH, Strutt AM, York MK, Kass JS. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010 Jul; 112(6):544-7. PMID: 20444540.
      View in: PubMed
    24. Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 3; 11(3):303-11. PMID: 20433413.
      View in: PubMed
    25. Lepow L, Van Sweringen J, Strutt AM, Jawaid A, MacAdam C, Harati Y, Schulz PE, York MK. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22. PMID: 20390792.
      View in: PubMed
    26. Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, Schulz PE. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010; 29(1):28-36. PMID: 20110698.
      View in: PubMed
    27. Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9. PMID: 20074230.
      View in: PubMed
    28. Karmonik C, York M, Grossman R, Kakkar E, Patel K, Haykal H, King D. An image analysis pipeline for the semi-automated analysis of clinical fMRI images based on freely available software. Comput Biol Med. 2010 Mar; 40(3):279-87. PMID: 20074720.
      View in: PubMed
    29. York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71. PMID: 19767016; PMCID: PMC2783787.
    30. Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, Schulz PE. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009; 28(2):145-52. PMID: 19690417.
      View in: PubMed
    31. Dulay MF, Levin HS, York MK, Mizrahi EM, Verma A, Goldsmith I, Grossman RG, Yoshor D. Predictors of individual visual memory decline after unilateral anterior temporal lobe resection. Neurology. 2009 May 26; 72(21):1837-42. PMID: 19470966.
      View in: PubMed
    32. Shirani P, Salamone AR, Lahijani E, York MK, Schulz PE. Lumbar puncture alleviates chorea in a patient with Huntington's disease and normal pressure hydrocephalus. Behav Neurol. 2009; 21(3):193-5. PMID: 20178144.
      View in: PubMed
    33. Dulay MF, Levin HS, York MK, Li X, Mizrahi EM, Goldsmith I, Verma A, Goldman A, Grossman RG, Yoshor D. Changes in individual and group spatial and verbal learning characteristics after anterior temporal lobectomy. Epilepsia. 2009 Jun; 50(6):1385-95. PMID: 18657174.
      View in: PubMed
    34. Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, Grossman RG, York MK. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8. PMID: 18514283; PMCID: PMC2735757.
    35. Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, York MK. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63. PMID: 18806240.
      View in: PubMed
    36. York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95. PMID: 17965146.
      View in: PubMed
    37. York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, Grossman RG. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866. PMID: 17624489.
      View in: PubMed
    38. Dulay MF, York MK, Soety EM, Hamilton WJ, Mizrahi EM, Goldsmith IL, Verma A, Grossman RG, Yoshor D, Armstrong DD, Levin HS. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006 Nov; 47(11):1922-30. PMID: 17116033.
      View in: PubMed
    39. McClure SM, York MK, Montague PR. The neural substrates of reward processing in humans: the modern role of FMRI. Neuroscientist. 2004 Jun; 10(3):260-8. PMID: 15155064.
      View in: PubMed
    40. York MK, Rettig GM, Grossman RG, Hamilton WJ, Armstrong DD, Levin HS, Mizrahi EM. Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia. 2003 Mar; 44(3):387-98. PMID: 12614395.
      View in: PubMed
    41. York MK, Levin HS, Grossman RG, Lai EC, Krauss JK. Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003 Feb; 25(1):110-21. PMID: 12607176.
      View in: PubMed
    42. York MK, Franks JJ, Henry RR, Hamilton WJ. Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychol Med. 2001 Oct; 31(7):1279-91. PMID: 11681554.
      View in: PubMed
    43. York MK, Levin HS, Grossman RG. Pallidotomy and psychological outcomes. J Neurosurg. 2001 May; 94(5):866-8. PMID: 11354429.
      View in: PubMed
    44. York MK, Baron EJ, Clarridge JE, Thomson RB, Weinstein MP. Multilaboratory validation of rapid spot tests for identification of Escherichia coli. J Clin Microbiol. 2000 Sep; 38(9):3394-8. PMID: 10970389; PMCID: PMC87392.
    45. Rettig GM, York MK, Lai EC, Jankovic J, Krauss JK, Grossman RG, Levin HS. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36. PMID: 10945807; PMCID: PMC1737102.
    46. York MK, Levin HS, Grossman RG, Hamilton WJ. Neuropsychological outcome following unilateral pallidotomy. Brain. 1999 Dec; 122 ( Pt 12):2209-20. PMID: 10581217.
      View in: PubMed
    47. York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol. 1999 Jun; 37(6):1727-31. PMID: 10325315; PMCID: PMC84935.
    48. Shannon KM, Penn RD, Kroin JS, Adler CH, Janko KA, York M, Cox SJ. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology. 1998 Feb; 50(2):434-8. PMID: 9484368.
      View in: PubMed
    49. Griffiths HA, Wilhelm KP, Robinson MK, Wang XM, McFadden J, York M, Basketter DA. Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard. Food Chem Toxicol. 1997 Feb; 35(2):255-60. PMID: 9146738.
      View in: PubMed
    50. York MK, Gibbs L, Chehab F, Brooks GF. Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol. 1996 Feb; 34(2):249-53. PMID: 8788995; PMCID: PMC228777.
    51. Cregan P, Fiss EH, Sullivan A, Brooks GF, York MK. Comparison of two BACTEC anaerobic culture media for recovery of anaerobic bacteria. Diagn Microbiol Infect Dis. 1993 Oct; 17(3):239-42. PMID: 8112035.
      View in: PubMed
    52. Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. Experience with selective reporting of susceptibility to antimicrobial agents. Am J Hosp Pharm. 1989 Sep; 46(9):1816-8. PMID: 2801717.
      View in: PubMed
    53. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest. 1988 Aug; 94(2):432-3. PMID: 3293934.
      View in: PubMed
    YORK's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _